The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. [electronic resource]
Producer: 20100811Description: 603-10 p. digitalISSN:- 1478-3231
- Animals
- Biopsy, Needle
- Blood Glucose -- analysis
- Diet
- Dietary Fats -- administration & dosage
- Disease Models, Animal
- Fatty Liver -- chemically induced
- Immunohistochemistry
- Immunosuppressive Agents -- pharmacology
- Inflammation Mediators -- analysis
- Insulin Resistance -- physiology
- Interleukin-6 -- analysis
- Leptin -- analysis
- Liver -- drug effects
- Liver Function Tests
- Male
- Mice
- Nitric Oxide Synthase -- metabolism
- Obesity -- drug therapy
- Probability
- RNA -- analysis
- Random Allocation
- Reference Values
- Reverse Transcriptase Polymerase Chain Reaction
- Thalidomide -- pharmacology
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.